Growth plates are specialized cartilage structures that ensure the elongation of most skeletal primordia during vertebrate development. They are made by chondrocytes that proliferate in longitudinal columns and then progress in a staggered manner towards prehypertrophic, hypertrophic and terminal maturation. Complex molecular networks control the formation and activity of growth plates, but remain incompletely understood. We investigated here the importance of the SoxC genes, which encode the SOX4, SOX11 and SOX12 transcription factors, in growth plates. We show that the three genes are expressed robustly in perichondrocytes and weakly in growth plate chondrocytes. SoxC Prx1Cre mice, which deleted SoxC genes in limb bud skeletogenic mesenchyme, were born with tiny appendicular cartilage primordia because of failure to form growth plates. In contrast, SoxC Col2Cre and SoxC ATC mice, which deleted SoxC genes primarily in chondrocytes, were born with mild dwarfism and fair growth plates. Chondrocytes in the latter mutants matured normally, but formed irregular columns, proliferated slowly and died ectopically. Asymmetric distribution of VANGL2 was defective in both SoxC Prx1Cre and SoxC ATC chondrocytes, indicating impairment of planar cell polarity, a noncanonical WNT signaling pathway that controls growth plate chondrocyte alignment, proliferation and survival. Accordingly, SoxC genes were necessary in perichondrocytes for expression of Wnt5a, which encodes a noncanonical WNT ligand required for growth plate formation, and in chondrocytes and perichondrocytes for expression of Fzd3 and Csnk1e, which encode a WNT receptor and casein kinase-1 subunit mediating planar cell polarity, respectively. Reflecting the differential strengths of the SOXC protein transactivation domains, SOX11 was more powerful than SOX4, and SOX12 interfered with the activity of SOX4 and SOX11. Altogether, these findings provide novel insights into the molecular regulation of skeletal growth by proposing that SOXC proteins act cell-and non-cellautonomously in perichondrocytes and chondrocytes to establish noncanonical WNT signaling crosstalk essential for growth plate induction and control. This article is protected by copyright. All rights reserved
INTRODUCTION
Most of the bones that compose the vertebrate skeleton develop upon cartilage templates. (1) These templates arise when mesenchymal progenitor cells coalesce at various skeletogenic sites in the embryo and commit to the chondrocyte lineage. Nascent chondrocytes surround themselves with an abundant, cartilage-specific extracellular matrix and actively proliferate.
They then organize growth plates, specialized structures responsible for the rapid and considerable elongation of skeletal elements during fetal and postnatal development. (2, 3) In order to do so, chondrocytes undergo a series of terminal differentiation steps in a staggered manner.
Chondrocytes located in the center of cartilage primordia initiate this progression and are followed first by proximal and then by distal neighbors. The result is a highly organized structure featuring at any time point layers of chondrocytes at successive stages of differentiation.
Immature chondrocytes form tightly packed longitudinal columns, within which they progressively slow down proliferation. Prehypertrophic chondrocytes growth-arrest and drastically alter their differentiation program, and hypertrophic cells enlarge massively. Terminal chondrocytes undergo apoptosis or convert to the osteoblast lineage and join efforts with perichondrium-derived osteoblasts, osteoclasts, blood vessels, and marrow precursors to achieve endochondral ossification, i.e., replace cartilage by bone tissue and marrow. (4) Many types of regulatory factors have been identified that control the spatial and temporal progression of growth plate chondrocytes. They include systemic and local hormones and growth factors, extracellular matrix components, extracellular and intracellular enzymes, and epigenetic and transcription factors. These factors act either cell-autonomously, i.e., they are produced and act within chondrocytes, or non-cell-autonomously, e.g., they are produced by perichondrocytes and signal to chondrocytes to alter cell differentiation, morphology, proliferation or survival. (3, 5, 6) This article is protected by copyright. All rights reserved
Genetic and non-genetic disturbances in the expression and activity of many of these factors have been shown to underlie various types of growth plate dysfunctions in humans. Severe forms can lead to neonatal death or incapacitating dwarfism, and mild forms to osteoarthritis and other skeleton degenerative diseases. (7, 8) Today, gaps remain in our knowledge of the factors that control growth plate formation and activity. Filling these gaps is crucial to uncover the causes of still unexplained skeletal dysplasias and to design efficient treatments for all types of cartilage diseases.
The family of SOX transcription factors has key roles in determining cell fate and differentiation in virtually every lineage. (9) All SOX proteins feature a DNA-binding domain closely related to that of SRY, the family founder encoded by the Sex-determining Region on the Y chromosome.
SOX proteins are distributed into eight groups (A to H) according to sequence identity. A SOX trio composed of SOX9 (SOXE protein), SOX5 and SOX6 (SOXD proteins) is well known for its pivotal roles in chondrocyte specification and differentiation. (10, 11) SOX9 directly transactivates cartilage-specific genes, and SOX5 and SOX6 boost SOX9's ability by securing its DNA binding. We recently unearthed that another SOX trio has key roles in skeletogenesis.
This trio is made of the three SOXC group members: SOX4, SOX11 and SOX12. These proteins are virtually identical in the SOX domain, but only share partial identity in a group-specific transactivation domain. (12, 13) This domain is most potent in SOX11 and least potent in SOX12.
The SoxC genes overlap in expression in the precursor cells of many organs, such as the heart, nervous system, kidney and pancreas. (12) (13) (14) (15) (16) (17) (18) They are essential in the development of these organs, primarily by ensuring cell survival, but were also described to participate in differentiation of neuronal and B cell precursors. (19, 20) With respect to skeletogenesis, the SoxC genes are largely co-expressed in the mesenchymal progenitors of cartilage and bone primordia. (17) They are This article is protected by copyright. All rights reserved dispensable for cell specification and proliferation, but instrumental for cell survival. and histological analysis has suggested that they were unable to develop growth plates. (21) We investigated this defect and its underlying mechanism in the present study. We show that SOXC proteins act at the top of a molecular cascade led by noncanonical WNT signaling to induce and ensure the proper organization and activity of growth plates.
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MATERIALS AND METHODS

Mice
Mice were used according to federal guidelines and as approved by the Cleveland Clinic
Institutional Animal Care and Use Committee. They harbored SoxC wild-type, conditional or null alleles (17, 22) and a Prx1Cre (23) , ATC (24) or Col2Cre (25) transgene. Unless otherwise indicated, females carrying SoxC ATC fetuses received doxycycline (Sigma) at 2 mg/ml in drinking water also supplemented with 5% sucrose from day 12.5 of pregnancy. All mouse lines were inbred for multiple generations on a mixed 129xB6 genetic background.
Skeletal preparations and in situ assays on embryo sections
Whole-mount skeletons were stained with alcian blue (cartilage) and alizarin red (mineralized tissue), as described. (21) Seven-µm-thick paraffin sections of embryo legs were generated following fixation of tissues in 4% paraformaldehyde (Electron Microscopy Sciences). Staining with alcian blue and nuclear fast red, TUNEL assay, and RNA in situ hybridization were performed as described. (21) The Tcf7l2 (Tcf4) probe corresponded to nucleotides 869 to 1579 in NM_001142924.1. The Fzd3 probe corresponded to nucleotides 3766 to 4510 in NM_021458.2.
The Csnk1e probe corresponded to nucleotides 1219 to 2005 in NM_013767.6. The cDNA for these probes were amplified by PCR, cloned in pCR4-TOPO (Invitrogen), and sequence-verified.
Other probes were as described. (12, 24, 26) Immunostaining was performed on 10-µm-thick frozen sections or 7-µm-thick paraffin sections of embryo legs fixed in 4% paraformaldehyde. Proteins were revealed using primary antibodies against cleaved caspase 3 (1/100, Cell Signaling 9661S), -catenin (1/100, Cell Signaling 8480) or acetyl-alpha-tubulin (1/500, Cell Signaling 5335), and
Alexa Fluor 594-conjugated goat anti-rabbit IgG as secondary antibody (1/200, Invitrogen This article is protected by copyright. All rights reserved A11037). They were also revealed using anti-VANGL2 primary antibody (1/50, Santa Cruz
Technologies sc-46561) in combination with Alexa Fluor 488-conjugated donkey anti-goat IgG
(1/100, Invitrogen A11055) for frozen sections and with streptavidin Alexa Fluor 594 (1/1000, Invitrogen S32356) with aid of TSA Plus Biotin kit (PerkinElmer NEL749A001KT) for paraffin sections. Cell nuclei were stained with Hoechst 33258 (2 µg/ml, Invitrogen). Cell proliferation was assayed using Click-iT ® EdU kit (Life Technologies) as described. (27) Pregnant females were injected intraperitoneally with EdU solution 2 h before embryo harvesting. Data were visualized with Leica CTR5000 microscope, captured with LEICA DFC310 FX digital color camera, and processed with Adobe Photoshop CS4 software. Confocal images were visualized with Leica TCS SP2 confocal microscopy system. Z-stack images were acquired at 0.5 µm intervals for 5 µm and then projected for analysis.
Quantitative RT-PCR
Growth plates were isolated from fetal mice by manually dissecting out cartilage epiphyses, bone, ligaments and muscle tissue, but preserving perichondrium. When compensatory regulation was analysed, growth plates were collected along with cartilage epiphyses and perichondrium. Tissue samples were collected in RNAlater (Life Technologies) and homogenized in TRIzol (Life Technologies). Cultured cell samples were directly collected in TRIzol. Total RNA extracted using TRIzol was further purified using RNeasy Mini Kit (Qiagen). cDNA was synthesized using Superscript III First-Strand Synthesis System (Life Technologies) and amplified with specific primers (Table S1 ) using SYBR Green PCR Master Mix (Applied Biosystems). PCR conditions were 1 cycle at 95°C for 10 min, and 40 cycles of 95°C for 15 sec and 60°C for 60 sec.
Relative mRNA levels were normalized to Gapdh RNA level and calculated using the 2^-∆∆Ct method.
Wnt5a analysis and reporter construction
We used the genome browser of the University of California at Santa Cruz (12) . Reporter activities were assayed using Dual-Light system (Life Technologies). SDS-PAGE and semi-dry western blotting on PVDF membranes (Bio-Rad) were performed under standard conditions. Membranes were incubated with anti-FLAG-HRP antibody (1/1000, Sigma A8592) in blocking solution containing 5% non-fat dry milk. Signals were detected using ECL Prime
Western Blotting Reagent (Life Technologies). Calvarium osteoblasts and rib chondrocytes were prepared from newborn mice, and SOX11, CRE, and lacZ adenovirus preparations were obtained and used at 100 plaque-forming units/cell as described. 
Electrophoretic mobility shift assays
Electrophoretic mobility shift assays (EMSA) were performed essentially as previously described (12) Briefly, EMSA probes (Table S2) were resolved by electrophoresis in 4% polyacrylamide native gels. Dried gels were exposed to X-ray films for 1 h to visualize signals.
Quantitative data presentation and statistical analysis
In vivo data were analyzed using control and mutant littermates. At least three measurements per animal and three pairs of animals were made to show reproducibility of phenotypes. In vitro data were analyzed using technical triplicates per condition, and experiments were repeated at least twice to demonstrate reproducibility of biological effects. Unless otherwise indicated, data are presented as average of experimental values with standard deviation. The two-tailed Student's ttest was used for statistical analysis. Differences were considered significant when the p value was less than 0.05.
RESULTS
SoxC genes are necessary for growth plate chondrocyte differentiation
We started this study by asking whether the severe brachysyndactyly of SoxC Prx1Cre fetuses was due to growth plate chondrocyte differentiation defects (Fig. 1A) . (21) RNA in situ hybridization of tibia sections from E18.5 fetuses showed that Sox9, Col2a1 and Acan expression was restricted to epiphyseal, columnar and prehypertrophic chondrocytes in control fetus tibias, as expected, but was encompassing all chondrocytes, perichondrium and joint cells in mutant tibias (Fig. 1B ). This expression pattern of Sox9 at E18.5 was as previously described for E14.5
SoxC
Prx1Cre embryos. (21) Occasionally, mutant fetuses featured an ectopic pocket of chondrocytes bulging from the perichondrium towards the central region of the tibia and always located on the external side. This cell pocket was not expressing Sox9, Col2a1 (encoding collagen type II) and Acan (aggrecan core protein). Pth1r (receptor for parathyroid hormone and parathyroid hormone-related peptide) and Ihh (Indian hedgehog), which mark prehypertrophic chondrocytes, and Col10a1 (collagen type X), which marks pre-and hypertrophic chondrocytes, were not expressed in mutant tibias, except for weak expression of Pth1r and Ihh in the ectopic bulge.
Pthlh (parathyroid hormone-related peptide) was properly expressed in mutant tibias in subarticular cartilage regions at both E14.5 and E18.5 ( Fig. 1B and S1 ). Runx2 and Sp7 (also known as Osx), which are weak markers of growth plate chondrocytes and robust markers of developing osteoblasts, were not or weakly expressed in mutant tibias. We thus concluded that SoxC genes are necessary to allow chondrocytes in cartilage primordia to promptly mature, form growth plates and induce endochondral ossification.
SoxC genes are expressed in growth plate chondrocytes and perichondrocytes
Prx1Cre is active in the entire limb bud mesenchyme that gives rise to chondrocytes, perichondrocytes and joint cells. Since these cell types crosstalk in order to coordinate all aspects of skeleton patterning, growth and maturation, the question arose as whether SoxC Prx1Cre fetuses were lacking growth plates as a consequence of SoxC absence in mesenchymal cells or in any of their derivatives. We previously showed that SoxC genes are actively expressed in skeletogenic mesenchymal cells, including perichondrium and presumptive joint cells, and more weakly expressed in E14.5 cartilage primordia. (12, 21) RNA in situ hybridization of E18.5 fetus sections revealed here that growth plate chondrocytes were readily expressing Sox11 at the epiphyseal stage and Sox4 at the terminal stage, but were weakly expressing the three SoxC genes in other chondrocytes compared to articular joint, perichondrium and bone cells (Fig. 2) . Thus, SoxC genes could direct growth plate formation through roles in precursor cells, chondrocytes, or adjacent cells.
SoxC expression in growth plate chondrocytes promotes skeletal growth
We tested whether SoxC genes have direct roles in growth plate chondrocytes by conditionally inactivating them using ATC. This bi-transgene expresses CRE recombinase in fully differentiated chondrocytes under the control of an Acan enhancer, but only in response to doxycycline, a member of the tetracycline antibiotics family. (24) Since SoxC genes have redundant functions in early skeletogenesis and many other processes, we generated triple and that long bones were on average 10% shorter than normal (Fig. 3A) . Histology analysis of tibias at E14.5 and E15.5 did not reveal remarkable abnormalities (Fig. 3B) . The total length of these elements was normal and so were the epiphyseal, columnar, and hypertrophic chondrocyte zones and the endochondral bone region. By E16.5, the cartilage columnar zone and endochondral bone region showed a trend towards shortening. At E18.5, all zones of the tibias were shorter, except epiphyses. Similarly, E18.5 SoxC Col2Cre fetuses, in which Col2Cre allowed inactivation of Sox4 and Sox11 in chondrocytes earlier than ATC and in few joint and perichondrium cells, (25) showed similar defects (Fig. 3C) . Thus, SoxC expression in chondrocytes is not required to form growth plates, but contributes to promoting skeletal elongation.
SOXC proteins are dispensable in chondrocytes for growth plate differentiation
RNA in situ hybridization and qRT-PCR assays revealed that the distribution pattern and level of Sox9 RNA were normal in SoxC ATC growth plates (Fig. 4A, B Having demonstrated that the shortness of SoxC ATC growth plates was not due to chondrocyte differentiation defects, we looked for other deficiencies in these mutant structures. Using TUNEL assay in proximal tibia growth plates, we observed as expected that control fetus chondrocytes were dying almost exclusively in the terminal zone (Fig. 5A ). In contrast, SoxC ATC chondrocytes were dying in a significantly higher proportion in the columnar (4.9% versus 0.1%), hypertrophic (9.5% versus 0.6%), and terminal zones (17.2% versus 11.4%). This untimely death of columnar and hypertrophic mutant chondrocytes was confirmed by cleaved caspase-3 immunostaining (Fig. 5B ). Other tibia and femur growth plates gave similar results ( Fig. S3A and B). We then measured cell proliferation through DNA incorporation of the thymidine analogue EdU in cells at the S phase of mitosis. SoxC ATC chondrocytes were proliferating at a normal rate in epiphyses, but instead of plateauing in the proximal half of the columnar zone, they immediately started to reduce their proliferation rate and they then growth-arrested slightly earlier than control cells in the prehypertrophic zone (Fig. 5C ). Last but not least, highmagnification pictures uncovered chondrocyte morphological and organizational defects in SoxC ATC growth plates (Fig. 5D ). Whereas control chondrocytes were flattened and forming straight, compact columns, often comprised of more than 6 cells, mutant chondrocytes were irregular in shape, often started prematurely to round up and enlarge, and were forming 3.5 times fewer columns of more than 6 well-aligned cells. Thus, SoxC expression in growth plate chondrocytes guarantees cell survival, optimal proliferation, fit shape and columnar organization.
SoxC genes are necessary for noncanonical WNT signaling in the growth plate
We then sought to decipher the mechanism(s) whereby SOXC proteins induce the formation and subsequently control the activity and organization of growth plates. We previously showed that SOXC proteins synergize with canonical WNT signaling to stabilize -catenin in perichondrium and joint surrounding nascent cartilage primordia. (21) However, immunostaining revealed here that the level of -catenin was normal or slightly increased in SoxC ATC chondrocytes (Fig. S4) .
Therefore, SOXC proteins must promote growth plate organization and activity through a mechanism that is independent of, and possibly even represses, canonical WNT signaling in chondrocytes. Since noncanonical WNT signaling antagonizes canonical WNT signaling (28, 29) and since the skeletal phenotype of SoxC Prx1Cre fetuses strikingly resembled that of Wnt5a -/-fetuses, which lack the noncanonical WNT5A ligand, (30, 31) we explored the possibility that WNT5A signaling was impaired in SoxC mutants. RNA in situ hybridization indicated that E14.5 SoxC Prx1Cre fetuses were expressing Wnt5a at a greatly reduced level in perichondrocytes and chondrocytes (Fig. 6A ). Fzd3 and Csnk1e expression was strongly reduced too, whereas
Ror2 expression was unchanged. Fzd3 and Ror2 encode WNT receptors that contribute to noncanonical WNT signaling. (32, 33) (32, 33) Immunostaining data revealed that significantly fewer chondrocytes were exhibiting asymmetrically localized VANGL2 in SoxC Prx1Cre and SoxC ATC tibias than in matched controls ( Fig. 6E and F) . Furthermore, primary cilia, which are also involved in planar cell polarity, were preferentially localized in the middle of columnar chondrocytes in control growth plates, as expected, (35) but on the lateral sides of the cells in SoxC ATC growth plates (Fig. 6G ).
We then asked whether SOXC proteins might directly activate the Wnt5a gene. Since the regulatory elements involved in the activation of the gene are unknown, we analyzed the entire gene and surrounding domains in order to identify putative enhancers. The gene promoter and transcribed region were carrying marks of activity in E14.5 mouse embryo limbs, as revealed by H3K4me3 (promoter), H3K27ac (active enhancer) and H3K4me1 (active and poised enhancers) histone modifications. They were also carrying marks of activity in E11.5 limb bud and mesoderm, as detected by DNase I hypersensitivity (nucleosome-free chromatin) ( Fig. 6H and   S5A ). Besides these regions, a 500-bp domain located 4 kb upstream of the gene stood out by a high degree of conservation and by H3K4me1, H3K27ac, and DNase I hypersensitivity marks.
These features strongly suggested that this domain could be an important enhancer. To test this possibility and the ability of SOXC proteins to activate this enhancer, we cloned the Wnt5a putative enhancer and promoter regions upstream of lacZ in the pWHERE reporter (Fig. S5B ).
Transient transfection of MC3T3-E1 cells (undifferentiated osteoblasts) with Wnt5a
Prom/pWHERE and Enh/Prom/pWHERE reporters along with SOXC expression plasmids showed that the enhancer had no activity without SOXC protein overexpression (Fig. 6I) .
Interestingly, SOXC proteins were not able to significantly modulate the activity of the promoter-only reporter, but were able to increase it by 2 to 5 fold when the enhancer was included in the reporter. As seen for other reporters, (12) SOX11 was the most potent of the three proteins. We then asked whether SOXC proteins mediate this effect by directly binding to the enhancer. Inspection of the most conserved region of the enhancer revealed multiple sequences closely resembling DNA motifs preferred by SOX proteins, including SOX4 and SOX11. (20, 36, 37) We selected three regions containing such sequences ( Fig. S5C and Table S2 ) and used them as DNA probes in electrophoretic mobility shift assay (Fig. 6J) To test whether inactivation of one or two SOXC genes affected the expression of the remaining wild-type SOXC genes through a positive or negative feedback loop, we measured mRNA levels in growth plates by qRT-PCR (Fig. S8 ). Each group of mutant samples showed significant reduction in expression of the SOXC genes deleted in growth plates by ATC but, while expression of the remaining SOXC alleles tended to decrease, there was no statistically significant difference.
Taken together, these data suggest a model whereby SOX12 tempers positive actions of SOX4
and SOX11 in growth plate chondrocytes; the combined levels of SOX4 and SOX11 proteins are amply sufficient to promote growth plate activity and neutralize the negative effect of SOX12;
hence, SOX12 deletion in an otherwise wild-type background does not affect growth plates, but when either SOX4 or SOX11 is deleted, the level of the remaining protein is insufficient to neutralize SOX12 and exert maximum effect on growth plates; it is sufficient to maximally promote growth plate activity only when SOX12 is also deleted. To add weight to this model, we tested the ability of SOX12 to interfere with the activity of SOX4 and SOX11 in vitro. Since the differential importance of the three proteins in vivo matched their relative transactivation strengths, we used a transactivation assay. We transfected COS-7 cells with SOXC expression plasmids and 6FXO-p89Luc, a reporter containing six tandem copies of a SOXC-binding site. (12) We used amounts of expression plasmids leading to saturating levels of reporter activation in order to establish competition conditions for the SOXC proteins. As expected, (12, 13) SOX4 and SOX11 were more potent transactivators than SOX12 (Fig. 7B) . When SOX12 was co-expressed with SOX4 or SOX11, it prevented its relatives from exerting maximum activity. We obtained similar results using the Wnt5a Enh/Prom/pWHERE reporter (Fig. S9) . These results thus support the conclusion that SOX12 likely acts in vivo as a rheostat to temper transactivation of target genes in cells expressing high levels of SOX4 and/or SOX11. It also nurtures the concept that the requirement of SOXC proteins for growth plate formation is not a secondary consequence of actions in cartilage primordia development, but truly involves live actions in perichondrocytes to induce growth plates.
DISCUSSION
Our study points to activation of noncanonical WNT signaling driven by WNT5A as the main non-cell-autonomous action of SOXC proteins on growth plates. This proposition is made at a time when the principle that perichondrocytes and chondrocytes entertain active crosstalk remains incompletely deciphered. This crosstalk has been convincingly demonstrated to include Indian Hedgehog and TGF , BMP, FGF, and canonical WNT family members. (1, 3, 38) However, none of these factors has been shown to be necessary and sufficient to initiate growth plate formation. Participation of noncanonical WNT signaling in this crosstalk has been proposed in several studies, but not definitively proven. Wnt5a -/-embryos were shown to fail to form growth plates, but whether this phenotype is a consequence of early cartilage primordia patterning and growth defects or a consequence of WNT5A absence at the time of growth plate formation remains unknown. (39) Forced expression of noncanonical WNT pathway mediators was shown to facilitate the columnar organization of growth plate chondrocytes in the chick and in cultured cells. (40, 41) Thus, although the direct importance of endogenous noncanonical WNT signaling in the growth plate remains untested, all data concur to propose that WNT5A could be at the top of the cascade leading to cartilage growth plate induction. This proposition is further endorsed by the observation that SoxC Prx1Cre embryos were unable to express Wnt5a, were impaired in their This article is protected by copyright. All rights reserved ability to express mediators of the pathway in perichondrocytes and chondrocytes, and strongly resembled Wnt5a -/-embryos in their inability to form growth plates. Concomitant expressions of Wnt5a and SoxC genes in perichondrocytes suggest the possibility that SOXC proteins directly transactivate Wnt5a. Validating this hypothesis, we identified here an enhancer located 4 kb upstream of Wnt5a and demonstrated that SOXC proteins are able to bind this enhancer to highly conserved sequences and to activate it. These data, along with recently put forward evidence that
Csnk1e is a direct target of SOX4 in early B cells, (20) establish a direct link between SOXC proteins and noncanonical WNT signaling and suggest that this link could be pivotal in multiple processes besides skeletogenesis. This conclusion is not depreciated by the fact that the overall phenotype of SoxC Prx1Cre embryos was not as dramatic as that of Ror2 -/-and Wnt5a -/-mice since SOXC genes were only deleted in cells expressing Prx1Cre and daughter cells.
All cell type-specific transcription factors required for growth plate chondrocyte differentiation that have been identified as of today act in a cell-autonomous manner. They include SOX5/6/9 in early, columnar and hypertrophic chondrocytes (24, 26) and RUNX2/3 and MEF2C from the prehypertrophic stage. (42) (43) (44) To our knowledge, SOXC proteins are the first cell type-specific transcription factors identified that control growth plate formation in a non-cell-autonomous manner. In addition to actions in perichondrocytes, we have also shown that SOXC proteins have significant roles in chondrocytes, but we ruled out major roles in the cell differentiation program.
We presented evidence that the contribution of SOXC proteins in chondrocytes in fetuses results in a 10-15% accrual in length of major bones. This gain corresponds to the difference between the 5 th and 95 th percentiles in human newborn length (45.5 and 54 cm) and is therefore not negligible. Considering that numerous genes contribute to skeletal growth, this finding fits with the notion that SOXC proteins intervene in pivotal regulatory pathways. SOXC proteins were This article is protected by copyright. All rights reserved found to facilitate growth plate chondrocyte columnar organization, proliferation and survival, as were WNT5A and VANGL2. (32, 33) Thus, the defects of SoxC mutant growth plates could be explained by reduced PCP signaling downstream of WNT5A. SOXC proteins were shown in many processes to ensure cell survival and several mechanisms have been proposed, such as facilitation of Hippo signaling in mesenchymal and neural cells and PI3K signaling in leukemia cells. (17; 45-49) SOXC proteins may thus promote growth plate chondrocyte survival through promoting noncanonical WNT signaling and other pathways.
We previously showed that SOXC proteins amplify canonical WNT/ -catenin signaling in joint and perichondrium cells, (21) whereas we showed here that they boost noncanonical WNT signaling, but do not affect or destabilize -catenin in growth plate chondrocytes. SOXC proteins can thus act differently or with different consequences in distinct cell types. A likely explanation for the different action of SOXC proteins on canonical WNT signaling in perichondrium/joint cells and chondrocytes is that the relative levels of SOX9 and SOXC proteins vary considerably between these cells. SOX9 was shown to repress -catenin signaling in early-stage and growth plate chondrocytes and was proposed to achieve this action by stimulating -catenin destruction in the APC/Axin complex. (24, 50, 51) We recently showed that SOXC proteins compete with SOX9
to enter the -catenin destruction complex and in contrast to SOX9 prevent -catenin degradation. (21) respond to the perichondrium-derived signal. Thus, SOX12 likely acts as a "SOXC rheostat": it may join forces with SOX4 and SOX11 in order to achieve a maximum output in cells expressing low level of the proteins, but it may prevent SOX4 and SOX11 from activating genes too strongly in cells expressing high levels of the proteins.
Humans with SOX4 or SOX12 mutations have not been identified yet, but heterozygous mutations in SOX11 were recently found to cause Coffin-Siris syndrome. (52) This condition has many features, including growth deficiency. Although the latter could have multiple causes, our findings suggest a primary defect in skeletal growth. They also suggest that other conditions comprising growth defects may exist in humans due to mutations in any of the SOXC genes.
In conclusion, SOXC proteins are critically involved in skeletal growth. for a representative experiment as averages of triplicates with standard deviation. Statistical significance of differences was calculated using the Student's t-test. A western blot shows the levels of SOXC proteins and a non-specific protein recognized by the FLAG antibody. A nonspecific band is also seen at the level of SOX12. This blot shows that differences in reporter activities obtained for SOX4 and SOX11 could be due differences in relative amounts of proteins made in cells, whereas the low transactivation activity of SOX12 and inhibitory effect of SOX12 on SOX4 and SOX11 activities are not due to differences in protein amounts. 
